HeberPAG® y carcinoma basocelular periocular: serie de casos con evolución a 5 años en La Habana, Cuba

Abstract

Objective: To describe the experience of the use of HeberPAG® in patients diagnosed with periocular basal cell carcinoma.

Materials and methods: A retrospective, single-center case series study was conducted in the Department of Ocular Plastic Surgery, including patients treated with HeberPAG®, diagnosed with periocular basal cell carcinoma and with 5 years of evolution.

Results: All treated patients corresponded to white skin color. The skin phototype according to the Fitzpatrick scale present in these patients was type II with 6 cases and phototype III with 3 cases. Of the 9 patients studied, 5 patients presented periocular basal cell carcinoma in the lower eyelid; in upper eyelid, external canthus, internal canthus, and eyebrow, 1 patient respectively.

Conclusion: The experience of using HeberPAG® in 9 patients diagnosed with periocular basal cell carcinoma was demonstrated, with satisfactory results in primary and recurrent tumors. This constitutes an additional therapy for the treatment of basal cell carcinoma with a stable behavior at 5 years, as well as a complete remission of 99%.